How a correct calculation becomes a wrong dose
We have catalogued what readers report, ranked by the size of the dosing error each produces.
Injection technique
Page 8 of 14 of this archive, newest first.
What the new the United Arab Emirates guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new Germany guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
How a correct calculation becomes a wrong dose
A pharmacist catches most of these in licensed practice. In this market there is no pharmacist, so the checks have to be structural.
What the new the United Arab Emirates guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Japan pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
What the new Australia guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Denmark pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
India pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
Nigeria pharmacy body issues counselling standards for semaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Spain pharmacy body issues counselling standards for semaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
What the new the United Kingdom guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new Germany guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new Norway guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new Brazil guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The intramuscular injection nobody intended
Skin thickness at the standard injection sites is approximately two millimetres in adults and varies remarkably little with body mass. That single finding is why short…
What the new France guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new the Netherlands guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The site you keep using is the site that stops working
Lipohypertrophic tissue is less painful to inject into, which is precisely why people keep injecting into it.
New Zealand pharmacy body issues counselling standards for liraglutide initiation
The evidence base is thin and the document says so, which is to its credit.